Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats

INTRODUCTION: Doxorubicin (DOX) is a well-known anticancer drug. However its clinical use has been limited due to cardiotoxic effects. One of the major concerns with DOX therapy is its toxicity in patients who are frail, particularly diabetics. Several studies suggest that mesenchymal stem cells (MS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Stem Cell Res Ther
Auteurs principaux: Ammar, Hania Ibrahim, Sequiera, Glen Lester, Nashed, Mira B., Ammar, Rasha I., Gabr, Hala M., Elsayed, Hany E., Sareen, Niketa, Rub, Ejlal Abu-El, Zickri, Maha B., Dhingra, Sanjiv
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4546321/
https://ncbi.nlm.nih.gov/pubmed/26296856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0142-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires